Iradimed Announces Fourth Quarter 2017 Financial Results

Iradimed (NASDAQ:IRMD), a leader in the development of innovative magnetic resonance imaging medical devices and the only known provider of non-magnetic intravenous infusion pump systems that are designed to be safe for use during MRI procedures, announced financial results for the three months and year ended December 31, 2017.

As quoted in the press release:

“I am very pleased with the strong finish to 2017. Fourth quarter 2017 revenue was nearly 12% higher than in the fourth quarter last year and nearly 18% higher than in the third quarter of 2017. Additionally, I am pleased with our accomplishments this year, especially in the areas of engineering and regulatory affairs. Working together, our engineering and regulatory affairs teams obtained FDA 510(k) clearance of our new MRI compatible patient vital signs monitor in October 2017. Additionally, the regulatory affairs team secured quality certifications that are required to sell our products in various markets including the European Union and Japan,” said Roger Susi, President and Chief Executive Officer of the Company.

Click here to read the full press release.